Europe to Spearhead Fertility Services Market
The global fertility
services market is predicted to grow at an 8.99% CAGR between 2019-2025, states
the latest Market Research Future (MRFR) report. Fertility services comprise of
various procedures used for treating fertility and genetic issues and help with
conception. Services such as frozen embryo replacement (FER), in-vitro
fertilization (IVF), artificial insemination, and infertility drugs help
infertile couples, the LGBT community, and single parents to procreate and
begin a family. These services help in conceiving as well as offer a safe and
better alternative to surrogacy.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6281
Various factors are
propelling the fertility services market growth. Some of these factors,
according to the Market Research Future report, include increasing incidence of
different medical ailments such as sexually transmitted diseases (STDs),
polycystic ovarian syndrome (PCOS), and endometrium tuberculosis which may
cause infertility, lack of financial stability, expanding career-oriented
population base, and increase in marketing and advertising of medical
facilities for promoting artificial reproduction. Additional factors pushing
market growth include health insurance portability, an increase in disposable
income, easy availability of advanced medical technologies in IVF devices, an
increase in infertility rates, and an increase in the prevalence of delayed
pregnancies.
On the flip side, low
awareness levels, reimbursement issues associated with fresh IVF cycles, and
high costs of fertility services are factors that are likely to deter the Fertility
Services Market growth over the forecast period.
Key Players:
Vitrolife (US), Ferring Pharmaceuticals Inc. (US), CARE
Fertility Group Limited (UK), CooperSurgical Inc (US), Irvine Scientific (US),
Cook Medical (US), and Merck KGaA (Germany)
Market Segmentation
·
The MRFR report offers a wide segmental analysis of the
fertility services market on the basis of underlying cause and treatment.
·
Based on the underlying cause, the fertility services market is
segmented into female and male infertility. Of these, the female infertility
segment will dominate the market over the forecast period on account of
endometrial tuberculosis, elapsed age of motherhood, the prevalence of obesity,
and other forms of medical conditions.
·
Based on treatment, the fertility services market has been
segmented into infertility drugs and assistive reproductive technology (ART).
The assistive reproductive technology segment has been again segmented into
frozen embryo replacement (FER), in-vitro fertilization (IVF), artificial
insemination, and others. Of these, the ART segment will lead the market over
the forecast period on account of its high success ratio, high adoption of this
treatment, expendable incomes of patients, and easy availability of
reimbursement policies covering such options.
Regional Analysis
By region, the fertility
services market report covers the latest trends and growth opportunities across
the Asia Pacific (APAC), Europe, the Americas, and the Middle East and Africa
(MEA), Of these, Europe will spearhead the market during the forecast period
for the significant increase in IVF, delayed marriages, low fertility rate,
reimbursement policies, and state funds.
The Americas will have
the second-largest share in the market over the forecast period on account of
the presence of a developed healthcare system, advanced technologies, and
growing incidence of hormonal imbalance in women due to obesity.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/fertility-services-market-6281
The Asia Pacific region
is projected to grow at the fastest pace over the forecast period on account of
the adoption of sophisticated technologies, favorable reimbursement policies,
gynecological conditions, and changing lifestyle conditions.
The fertility services
market in the Middle East and Africa is predicted to have a slow growth over
the forecast period chiefly for the scarcity of advanced medical facilities,
fewer investments in the healthcare industry, cultural and religious factors,
scarcity in skilled medical professionals, and lack of awareness.
Industry News
November 2019: American
Hospital Dubai has recently entered into a partnership with the largest
provider of IVC, Livio AB, with an aim to facilitate the creation of an IVF
center that offers the finest possible pregnancy outcomes in the Middle East.
Comments
Post a Comment